---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-095068"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:52:25.788346+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve reverse stock split, warrant exercise, and equity plan increase at special meeting

## Summary
- Proposal to approve exercise of warrants for up to 6,014,493 shares passed with 259,282 for, 14,312 against.
- Amendment to 2022 Equity Incentive Plan to increase shares by 500,000 approved: 253,106 for, 21,172 against.
- Reverse stock split authorization (ratio 1:3 to 1:5) approved: 675,553 for, 77,032 against.
- Adjournment proposal also approved: 674,854 for, 77,335 against.
- Meeting held Nov 6, 2024; quorum of ~40.7% voting shares represented.

## SEC filing metadata
- accession: 0001213900-24-095068
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390024095068/0001213900-24-095068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390024095068/ea022027801-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-095068
- JSON: https://secwatch.observer/filing/0001213900-24-095068.json
- Plain text: https://secwatch.observer/filing/0001213900-24-095068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.